Allison R Dirk's Form 4/A amendment
AmendedAddus HomeCare Corp (ADUS) · filed Nov 27, 2024
- Accession no.
- 0000950170-24-131628
- Filed
- Nov 27, 2024
- Trade date
- Nov 25, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Nov 26, 2024
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.54M. It was filed 2 days after the trade.
This amendment replaces 0000950170-24-131186 (filed Nov 26, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Allison R DirkCIK 0001253500 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Common Stock | MOption exerciseAcquired | +12,500 | $19.71 | +$246,375 | 91,897 | Direct | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −3,467 | $122.58F3 | −$424,984.86 | 88,430 | Direct | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −8,517 | $123.31F4 | −$1,050,231.27 | 79,913 | Direct | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −253 | $124.19F5 | −$31,420.07 | 79,660 | Direct | |
| Nov 25, 2024 | Common Stock | SSaleDisposed | −263 | $125.17F6 | −$32,919.71 | 79,397 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 75,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Form 4 filed on 11/26/2024 erroneously reported 75,000 options exercised in column 4 of Table I and columns 5 and 7 of Table II. The purpose of this amendment is to correct those amounts and the related totals in column 5 of Table I.
- F2
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.92 to $122.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.92 to $123.91, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.95 to $124.22, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.25, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
All options are fully vested.